Acadia Pharmaceuticals, Inc. cmn shares owned by Group One Trading
Quarter-by-quarter ownership of Acadia Pharmaceuticals, Inc. cmn shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Acadia Pharmaceuticals, Inc. cmn
Tip: Access up to 7 years of quarterly data
All positions including Acadia Pharmaceuticals, Inc. cmn held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Acadia Pharmaceuticals, Inc. cmn by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 69k | 21.34 |
| 2025-06-30 | $375k | 17k | 21.57 |
| 2025-03-31 | $135k | 8.1k | 16.61 |
| 2024-12-31 | $899k | 49k | 18.35 |
| 2024-09-30 | $883k | 57k | 15.38 |
| 2024-06-30 | $717k | 44k | 16.25 |
| 2024-03-31 | $1.3M | 71k | 18.49 |
| 2023-09-30 | $11M | 524k | 20.84 |
| 2023-06-30 | $1.3M | 52k | 23.95 |
| 2023-03-31 | $297k | 16k | 18.82 |
| 2022-12-31 | $124k | 7.8k | 15.92 |
| 2022-09-30 | $288k | 18k | 16.36 |
| 2022-06-30 | $1.3M | 94k | 14.09 |
| 2022-03-31 | $470k | 19k | 24.23 |
| 2021-12-31 | $565k | 24k | 23.35 |
| 2021-09-30 | $357k | 22k | 16.60 |
| 2021-06-30 | $827k | 34k | 24.40 |
| 2021-03-31 | $7.2M | 277k | 25.80 |
| 2020-12-31 | $16M | 304k | 53.46 |
| 2020-09-30 | $13M | 304k | 41.25 |
| 2020-06-30 | $14M | 286k | 48.47 |
| 2020-03-31 | $12M | 281k | 42.25 |
| 2019-12-31 | $18M | 422k | 42.78 |
| 2019-09-30 | $9.5M | 263k | 35.99 |
| 2019-06-30 | $22M | 803k | 26.73 |
| 2019-03-31 | $2.0M | 74k | 26.85 |
| 2018-12-31 | $1.0M | 62k | 16.18 |
| 2018-09-30 | $2.6M | 124k | 20.76 |
| 2018-06-30 | $1.7M | 112k | 15.27 |
| 2018-03-31 | $4.4M | 197k | 22.47 |
| 2017-12-31 | $7.6M | 252k | 30.11 |
| 2017-09-30 | $7.4M | 196k | 37.67 |
| 2017-06-30 | $6.4M | 229k | 27.89 |
| 2017-03-31 | $7.4M | 215k | 34.38 |
| 2016-12-31 | $11M | 389k | 28.84 |
| 2013-06-30 | $13M | 700k | 18.15 |
Top funds holding Acadia Pharmaceuticals, Inc. cmn
View all funds holding Acadia Pharmaceuticals, Inc. cmn